Please assess the completion status of the following clinical trial:

Trial Title: The Vaginal Progesterone and Cerclage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age from 20 - 35 years old.~* Pregnant from (12- 14 weeks) gestation.~* Singleton pregnancy.~* The pregnant women who have a history of second trimester pregnancy loss with painless cervical dilatation or have prior cerclage placement for cervical insufficiency or have a history of spontaneous preterm.~Exclusion Criteria:~* Multiple gestations.~* Congenital fetal malformation in the current pregnancy.~* Women with history of thromboembolism or bleeding disorders.~* Uncontrolled diabetes mellitus.~* Chromosomal abnormalities affecting one of the couples.~* Women refuse to participate in the study~* Antiphospholipid syndrome

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 35 Years
- Healthy Volunteers: f

Study Arms:
- Vaginal progesterone group (Type: ACTIVE_COMPARATOR): Will receive progesterone pessaries 400 mg once daily vaginally
- No progesterone group (Type: NO_INTERVENTION): Will receive nothing

Based on this trial design, predict the completion outcome and termination type (if applicable).